Cost of ruxolitinib

The Orphan Druganaut Blog has done research into the cost of Ruxolitinib (Novartis's Jakavi in the EU; Incyte Corporation's Jakafi in the

were estimated to be $5302 with 0.75% ruxolitinib cream and $4228 with 1.5% ruxolitinib cream. vehicle and is estimated to reduce the indirect cost burden on

Ruxolitinib-Phosphate is a generic medicine. The guaranteed lowest cost of Brand Jakafi / Generic Ruxolitinib Phosphate Tablets 5mg @ $81.21

The overall incremental cost-effectiveness ratio (ICER) was $128,600/QALY. The ICER was most sensitive to the efficacy of ruxolitinib, utility in the hematocrit control state, and cost of ruxolitinib. Results of the PSA showed that ruxolitinib would be cost-effective 73% of the time using a willingness-to-pay (WTP) threshold of $150,000/QALY.

When including the 11% discount rate to capitalize costs, the full cost was estimated to be $802 million. Ruxolitinib Is Under Investigation

cost of care, highlighting the need for a standardized operating Ruxolitinib May Elicit Skin/Joint, Chronic GVHD Responses.

Total cost, 945,000.00. Registration phase, Registration application Therapeutic value. Current treatment options, Ruxolitinib.

the cost of eligible prescription drugs and Based on economic considerations and the submitted product price, ruxolitinib was not cost.

by AT Gerds 2024 Cited by 1Monthly medical costs were numerically lower in patients who had ≥1 fill of ruxolitinib versus those who did not fill a prescription for ruxolitinib ($6,553 vs